The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnimalcare Grp Regulatory News (ANCR)

Share Price Information for Animalcare Grp (ANCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 236.00
Bid: 232.00
Ask: 240.00
Change: 0.00 (0.00%)
Spread: 8.00 (3.448%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 236.00
ANCR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

10 Jun 2019 14:55

RNS Number : 7161B
Animalcare Group PLC
10 June 2019
 

 10 June 2019

 

ANIMALCARE GROUP PLC

 (the "Company")

Grant of options to Persons Discharging Managerial Responsibility ("PDMRs")

 

Animalcare Group plc (AIM: ANCR), the pan-European Animal Health business, announces that, on 6 June 2019, nil-cost options over a total of 425,279 ordinary shares with a nominal value of 20p per share ("the Options") were awarded to certain Executive Directors and PDMRs of the Company and to members of the Leadership Team pursuant to the Company's Long Term Incentive Plan.

 

The awards will normally vest three years after the date of grant subject to the following performance criteria being met over the three year financial period ending 31 December 2021. The Options will vest to the extent the following performance conditions based on EPS and TSR are met:

 

Earnings Per Share growth

Extent to which EPS tranche will vest

Less than 3%

0%

3%

25%

8%

100%

Between 3% and 8%

Between 25% and 100% on a straight line basis

 

Rank of the Company's TSR compared to the Comparator Group

Extent to which the TSR tranche will vest

Upper quartile or above

100%

Between median and upper quartile

Pro rata between 25% and 100% on a ranking basis

Median

25%

Below median

0%

 

50% of the option award will be subject to the EPS performance condition and the remaining 50% will be subject to the TSR performance condition. Accordingly, if one of the performance conditions is met but the other is not, the Option award will vest in part. 

 

After the grant of the Options, the PDMRs set out below hold the following Options and ordinary shares:

 

PDMR

Options Awarded

Total Options

Ordinary Shares

Jennifer Winter

177,570

 

177,570

 

0

Chris Brewster

76,636

 

76,636

280,513

 

Options over a further 171,073 ordinary shares were granted to members of the Leadership Team.

 

The notification in respect of the Option Awards set out in the Annex below was made subject to the requirements of Article 19 of the Market Abuse Regulation:

 

ANNEX

 

 1

 

Details of the person discharging managerial responsibilities / person closely associated 

a)

 

Name

Jennifer Winter, Chief Executive Officer

2

 

Reason for the notification

a)

 

Position/status

 

See 1(a) above - Ms Winter is classified as a PDMR of the Company

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

 

Name

 

Animalcare Group plc

b)

LEI

 

 213800A7XPQ528RMCC72

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Options in respect of the Long Term Incentive Plan ("LTIP") over ordinary shares of 20p each

b)

Identification code 

 

 GB0032350695

c)

 

Nature of the transaction(s)

 

Issue of options

d)

 

Price(s) and volume(s)

Volume(s):

Nil cost options over 177,570 shares

Price:

£Nil

e)

 

Aggregated information 

- Aggregated volume

- Price

 N/A

 

f)

 

Date of the transaction

6 June 2019

g)

 

Place of the transaction

Outside a trading venue

 

 1

 

Details of the person discharging managerial responsibilities / person closely associated 

a)

 

Name

Chris Brewster, Chief Financial Officer

2

 

Reason for the notification

a)

 

Position/status

 

See 1(a) above - Mr Brewster is classified as a PDMR of the Company

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

 

Name

 

Animalcare Group plc

b)

LEI

 

 213800A7XPQ528RMCC72

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Options in respect of the Long Term Incentive Plan ("LTIP") over ordinary shares of 20p each

b)

Identification code 

 

 GB0032350695

c)

 

Nature of the transaction(s)

 

Issue of options

d)

 

Price(s) and volume(s)

Volume(s):

Nil cost options over 76,636 shares

Price:

£Nil

e)

 

Aggregated information 

- Aggregated volume

- Price

 N/A

 

f)

 

Date of the transaction

6 June 2019

g)

 

Place of the transaction

Outside a trading venue

 

Animalcare Group plc

Tel: 01904 487 687

Chris Brewster, Chief Financial Officer

and Company Secretary

 

 

Panmure Gordon - Nominated Adviser and Broker

Tel: 020 7886 2500

Corporate Finance

 

Freddy Crossley / Emma Earl

 

Corporate Broking

 

 

Consilium Strategic Communications

Tel: 020 3709 5709

Amber Fennell/Angela Gray/Olivia Manser

Animalcare@consilium-comms.com

 

 

About Animalcare www.animalcaregroup.co.uk

Animalcare Group plc is a UK AIM listed veterinary sales and marketing organisation resulting from the merger of Animalcare and Ecuphar NV in July 2017. Animalcare operates in 32 countries in Europe and a further 16 worldwide. The company is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBXGDLDUBBGCG
Date   Source Headline
25th Apr 20247:00 amRNSGrant of options and PDMR Dealing
11th Apr 20242:57 pmRNSSale of equity in STEM Animal Health Inc.
9th Apr 20248:22 amRNSInvestor presentation via Investor Meet Company
9th Apr 20247:00 amRNSPreliminary Unaudited Full Year Results 2023
28th Feb 20247:00 amRNSDisposal of Identicare Ltd
29th Jan 202410:27 amRNSNotification of Major Holding
25th Jan 20247:00 amRNSTrading Update and Notice of 2023 FY Results
9th Nov 20232:01 pmRNSNotification of Major Holding
1st Nov 202311:38 amRNSNotification of Major Holding
12th Oct 20231:28 pmRNSExercise of Options and Total Voting Rights
5th Oct 20237:00 amRNSPDMR Dealing – Dividend Reinvestment Plan
2nd Oct 20234:42 pmRNSNotification of Major Holding
26th Sep 20237:00 amRNSInterim Results for six months ended 30 June 2023
19th Sep 20239:04 amRNSNotification of Major Holding
18th Sep 20236:23 pmRNSNotification of Major Holding
27th Jul 20237:00 amRNSHalf year Trading Update and Notice of Interims
21st Jun 20237:00 amRNSOption Exercise, Admission and Total Voting Rights
13th Jun 20233:50 pmRNSResult of 2023 AGM
19th May 20237:00 amRNS2022 Annual Report and Notice of 2023 AGM
28th Mar 20237:00 amRNS2022 Preliminary Results
26th Jan 20237:00 amRNSTrading Update and Notice of Full Year Results
21st Dec 20223:43 pmRNSNotification of Major Holding
21st Nov 20223:39 pmRNSNotification of Major Holding
14th Nov 20227:00 amRNSChange of Registered Office
20th Oct 20227:34 amRNSCorrective announcement - H1 2022 Interim Results
27th Sep 20227:00 amRNSInterim results for six months ended 30 June 2022
26th Jul 20227:00 amRNSH1 Trading Update and Notice of Interim Results
7th Jun 20225:11 pmRNSResult of 2022 AGM and changes to Board Committees
12th May 20227:00 amRNS2021 Annual Report and Notice of 2022 AGM
3rd May 20227:00 amRNSChanges to Board of Directors
29th Apr 20222:19 pmRNSGrant of options and PDMR Dealing
12th Apr 20221:40 pmRNSNotification of Major Holding
29th Mar 20227:00 amRNSFull year results 2021
24th Mar 20227:00 amRNSAnimalcare and Orthros form VHH R&D collaboration
10th Feb 20222:46 pmRNSAppointment of Non-Executive Director
25th Jan 20227:00 amRNSTrading Update & Notice of Full Year Results
8th Nov 20211:27 pmRNSGrant of options
26th Oct 20219:27 amRNSNotification of Major Holding
5th Oct 20213:22 pmRNSNotification of Major Holding
28th Sep 20217:00 amRNSInterim Results H1 2021
16th Sep 202110:46 amRNSNotification of Major Holding
9th Sep 20211:44 pmRNSNotification of Major Holding
2nd Aug 20217:00 amRNSNotification of Total Voting Rights
30th Jul 202112:00 pmRNSNotification of Major Holding
22nd Jul 20217:00 amRNSHalf Year Trading Update and Notice of Results
15th Jul 20214:11 pmRNSNotification of Major Holding
15th Jul 20217:00 amRNSDirector/PDMR Notification
12th Jul 20214:15 pmRNSNotification of Major Holding
12th Jul 20214:00 pmRNSNotification of Major Holding
12th Jul 20213:35 pmRNSNotification of Major Holding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.